NR3C2 and kidney disorder: Gene deletion studies have shown that MR signalling in myeloid cells reduces inflammation and fibrosis in non-diabetic mouse models of cardiac or kidney disease [9–12], suggesting that this could also be an important pathological pathway in diabetic cardiorenal disease.